Albendazole/Pyrantel Embonate

阿苯达唑/恩波酸噻嘧啶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlbendazole/Pyrantel Embonate
Drug Alias Name复方阿苯达唑片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated proteins inhibitors
TargetsMicrotubule-associated proteins
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A